6 ways big data is driving personalized medicine revolution

Drugs can be expensive, difficult to research, hard to get approved, and, according to a recent report, don't work on large parts of the population. These factors likely put a great deal of pressure on pharmaceutical companies to research drugs that have the highest probability of turning a profit rather than those that could help the most people. But this paradigm may be shifting with the help of IT and big data. The industry has found new ways IT and big data are making a major impact on the way drugs are being researched by helping create more effective trials. Before we examine the benefits IT is bringing to this arena, let's try to understand what's wrong with the traditional (and ongoing) way most drugs enter trial.